Dinner is the meal Im most likely to cook for the family, and I always keep it simple: a protein, a carb, a veggie, and plenty of flavor
MAUD-T2D trial: Patients with T2D and markers of more severe AUD, comparing newer GLP-1 RAs to FDA-approved medications for AUD (MAUD: acamprosate, disulfiram, or naltrexone)
GLP-1 microdosing involves off-label, fractional use of a GLP-1 medication, which means taking a smaller dose than what the drug manufacturer recommends
A clinician may consider: Is the symptom mild, moderate, or severe
In Phase 3 trials, constipation affected up to 26.1% of people taking retatrutide, compared with 10.9% on placebo
Future outlook: what comes next for both compounds The peptide weight loss landscape is evolving rapidly, and both cagrilintide and retatrutide sit at the center of that evolution